Biotech programs outgrow their tools. Spreadsheets that worked in discovery buckle under IND-enabling work, and software built for large sponsors tends to come with heavy setup a lean team can't absorb. LabRelations takes a different approach. Our CTMS and QMS platforms are designed to start simple and grow with the program, without cutting corners on the rigor GCP and 21 CFR Part 11 eventually demand. There's still setup, and our team is with you through it - but we've done the hard work upfront so you're running sooner, with less complexity to manage as the science moves into the clinic.
For emerging biotechs heading toward first-in-human, that means capable software without a platform swap at every stage.
LabRelations Clinical Platform and Quality Platform grow with the program - from IND-enabling work through first trials.
When a program crosses into the clinic, we're replacing spreadsheets and email with a single source of truth. Our CTMS is built so a small clinical team can run a first-in-human study without the overhead larger sponsors take for granted, and stay inspection-ready under GCP and 21 CFR Part 11.
QMS for documents, SOPs, deviations, change control, training, and CAPA. Light enough to stand up before you have a full quality department, deep enough to take a program through IND-enabling work without re-platforming. When an SOP changes, the right people get re-trained automatically.
A mix of people who've worked in biotech (usually from translational science, clinical operations, and quality) backed by technical people for configuration needs inside the platform itself. They've seen what a lean team looks like on the way to IND, and they don't expect a 50-person QA department.
